Clinical/scientific notes

R. Iorio; C. F. Lucchinetti; V. A. Lennon; C. Costanzi; S. Hinson; B. G. Weinshenker; S. J. Pittock

doi:10.1212/WNL.0b013e3182343377

Clinical/scientific notes

R. Iorio, C. F. Lucchinetti, V. A. Lennon, C. Costanzi, S. Hinson, B. G. Weinshenker, S. J. Pittock

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1644-1646
Number of pages	3
Journal	Neurology
Volume	77
Issue number	17
DOIs	https://doi.org/10.1212/WNL.0b013e3182343377
State	Published - Oct 25 2011

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e3182343377

Cite this

@article{2526cf3b6a5448a69b859dca92a5b394,

title = "Clinical/scientific notes",

author = "R. Iorio and Lucchinetti, {C. F.} and Lennon, {V. A.} and C. Costanzi and S. Hinson and Weinshenker, {B. G.} and Pittock, {S. J.}",

note = "Funding Information: Disclosure: Dr. Iorio reports no disclosures. Dr. Lucchinetti receives royalties from the publication of Blue Books of Neurology: Multiple Sclerosis 3 (Saunders Elsevier, 2010); receives research support from the NIH, the National MS Society, and the Guthy Jackson Charitable Foundation ; and receives license royalties for a patent relating to aquaporin-4 antibodies for diagnosis of neuromyelitis optica. Dr. Lennon is a named inventor on a patent ( #7101679 issued 2006) relating to aquaporin-4 antibodies for diagnosis of neuromyelitis optica and receives royalties for this technology; is a named inventor on patents (#12/678,350 filed 2010 and #12/573,942 filed 2008) that relate to functional AQP4/NMO-IgG assays and NMO-IgG as a cancer marker; and receives research support from the Guthy Jackson Charitable Foundation . Dr. Costanzi reports no disclosures. Dr. Hinson is a named inventor on a patent ( #12/573,942 filed 2008) that relates to functional AQP4/NMO-IgG assays. Dr. Weinshenker serves on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of the Canadian Journal of Neurological Sciences and the Turkish Journal of Neurology; has received research support from Genzyme Corporation and the Guthy Jackson Charitable Foundation ; and receives license royalties for a patent relating to aquaporin-4 antibodies for diagnosis of neuromyelitis optica. Dr. Pittock is a named inventor on patents ( #12/678,350 filed 2010 and #12/573,942 filed 2008 ) that relate to functional AQP4/NMO-IgG assays and NMO-IgG as a cancer marker; receives research support from Alexion Pharmaceuticals, Inc., the Guthy Jackson Charitable Foundation, and the NIH. ",

year = "2011",

month = oct,

day = "25",

doi = "10.1212/WNL.0b013e3182343377",

language = "English (US)",

volume = "77",

pages = "1644--1646",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "17",

}

TY - JOUR

T1 - Clinical/scientific notes

AU - Iorio, R.

AU - Lucchinetti, C. F.

AU - Lennon, V. A.

AU - Costanzi, C.

AU - Hinson, S.

AU - Weinshenker, B. G.

AU - Pittock, S. J.

N1 - Funding Information: Disclosure: Dr. Iorio reports no disclosures. Dr. Lucchinetti receives royalties from the publication of Blue Books of Neurology: Multiple Sclerosis 3 (Saunders Elsevier, 2010); receives research support from the NIH, the National MS Society, and the Guthy Jackson Charitable Foundation ; and receives license royalties for a patent relating to aquaporin-4 antibodies for diagnosis of neuromyelitis optica. Dr. Lennon is a named inventor on a patent ( #7101679 issued 2006) relating to aquaporin-4 antibodies for diagnosis of neuromyelitis optica and receives royalties for this technology; is a named inventor on patents (#12/678,350 filed 2010 and #12/573,942 filed 2008) that relate to functional AQP4/NMO-IgG assays and NMO-IgG as a cancer marker; and receives research support from the Guthy Jackson Charitable Foundation . Dr. Costanzi reports no disclosures. Dr. Hinson is a named inventor on a patent ( #12/573,942 filed 2008) that relates to functional AQP4/NMO-IgG assays. Dr. Weinshenker serves on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of the Canadian Journal of Neurological Sciences and the Turkish Journal of Neurology; has received research support from Genzyme Corporation and the Guthy Jackson Charitable Foundation ; and receives license royalties for a patent relating to aquaporin-4 antibodies for diagnosis of neuromyelitis optica. Dr. Pittock is a named inventor on patents ( #12/678,350 filed 2010 and #12/573,942 filed 2008 ) that relate to functional AQP4/NMO-IgG assays and NMO-IgG as a cancer marker; receives research support from Alexion Pharmaceuticals, Inc., the Guthy Jackson Charitable Foundation, and the NIH.

PY - 2011/10/25

Y1 - 2011/10/25

UR - http://www.scopus.com/inward/record.url?scp=82955236178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955236178&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3182343377

DO - 10.1212/WNL.0b013e3182343377

M3 - Article

C2 - 21998320

AN - SCOPUS:82955236178

SN - 0028-3878

VL - 77

SP - 1644

EP - 1646

JO - Neurology

JF - Neurology

IS - 17

ER -

Clinical/scientific notes

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this